You searched for "Simulation"
GREG (Gloucestershire Research & Education Group): Introduction to Grading Diabetic Retinopathy (DR)
11 November 2024
-12 November 2024
This course has been designed to introduce students to grading in diabetic retinopathy, based around national standards. It consists of pre-course online learning, and two days of face to face training. It explores diabetic retinopathy in depth, and provides students with an extensive understanding of how this condition is classified.
The teaching is provided by Gloucestershire Research & Education Group and participants will receive an in-house certificate from the Gloucestershire Research & Education Group, on successful completion.
Healthcare Science (Ophthalmic Imaging) Degree Apprenticeship for Employers
16 May 2024
|
imaging, healthcare scientist, allied, profressions, education, study, opportunities, vacancies
Hear from the team at Manchester Royal Eye Hospital and about how degree apprenticeships from University of Gloucestershire have helped their department.
Tocilizumab in Graves’ orbitopathy
This prospective European study looks at the response to tocilizumab in corticosteroid-resistant disease. Tocilizumab (TCZ) is a monoclonal antibody that competitively inhibits IL-6 binding to its receptor. Unlike teprotumumab, the advantage of TCZ is that it is already used within...The impact of obstructive sleep apnoea monitoring functionality on smartwatches: a new frontier for ophthalmologists
3 June 2024
| Yu Jeat Chong, Matthew Azzopardi
|
EYE - General
Dawn of a new era in wearable technology? Smartwatches have really stepped up their game and have evolved from telling time to keeping an eye on our health. In February 2024, the United States Food and Drug Administration (FDA) gave...
The David J Apple International Laboratory for Ocular Pathology – a legacy of pioneering IOL research
David Apple and Gerd Auffarth. The Apple Lab at the David J Apple Center for Vision Research in Heidelberg is a thriving international laboratory for research into intraocular devices. The lab continues the work of David J Apple, a world-renowned...Haag-Streit UK appoints a new Regional Sales Manager
12 October 2023
|
Recruitment & Personnel, Company Profiles
Haag Streit UK is pleased to announce the appointment of Martin Rescorle in the role of Regional Sales Manager.
Ophthalmic mentors: Professor Carrie MacEwen
1 February 2015
| Rod McNeil
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
Caroline (Carrie) MacEwen is a Consultant Ophthalmologist at Ninewells Hospital and Medical School, Dundee, and Head of the Ophthalmology Department at the University of Dundee (Honorary Professor). She trained in Glasgow, Dundee and London. Carrie took over as President of...
Ophtherminator 3 - Rise of the Machines
“Bring back life form, priority one, all other priorities are rescinded.” Film buffs will spot this as a chilling quote spoken by Ash (Ian Holm) from the classic sci-fi horror movie Alien (1979). Ash (spoiler alert) is a Hyperdyne Systems...
Intravitreal Ziv-Aflibercept: safety analysis
7 December 2020
| Su Young
|
EYE - Vitreo-Retinal
Ziv-Aflibercept (Zaltrap; Sanofi-Aventis U.S LLS, Bridgewater, NJ) was originally introduced as an intravenous formulation for metastatic colorectal cancer. The adoption of Ziv-Aflibercept in ophthalmic practice was similar to bevacizumab, and reports have previously examined one to two year visual outcomes...
Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
1 October 2018
| Rod McNeil
|
EYE - General
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
Situation analysis of diabetic retinopathy services in eleven countries
1 December 2015
| Peter Blows, Tunde Peto, Heiko Philippin, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A five-year project funded by The Queen Elizabeth Diamond Jubilee Trust is facilitating development of diabetic retinopathy services (DRS) to reduce unnecessary blindness in 10 Commonwealth countries through the establishment of a capacity-building network, the DR-NET part of the Commonwealth...
